Evolent Health Inc
NYSE:EVH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.71
34.72
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Evolent Health Inc
Evolent Health Inc
Accounts Receivables
Evolent Health Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Evolent Health Inc
NYSE:EVH
|
Accounts Receivables
$407.9m
|
CAGR 3-Years
33%
|
CAGR 5-Years
40%
|
CAGR 10-Years
43%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Accounts Receivables
$301.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Accounts Receivables
$89.7m
|
CAGR 3-Years
50%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Accounts Receivables
$107.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Accounts Receivables
$251.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Accounts Receivables
$126.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
Glance View
Evolent Health Inc. emerged in 2011 from a collaboration between The Advisory Board Company and the University of Pittsburgh Medical Center, with a mission to reshape healthcare delivery in the United States. As the healthcare landscape shifted towards value-based care models, where providers are compensated for keeping patients healthy rather than on the volume of services delivered, Evolent positioned itself as a pivotal partner for healthcare systems aiming to transition smoothly into this new paradigm. The company's core offerings revolve around its technology-driven platform, which integrates data analytics, care management, and clinical expertise to enable healthcare providers and payers to deliver more efficient and patient-centric care. By providing these services, Evolent helps its clients reduce costs and improve patient outcomes, thus thriving in a rapidly evolving industry. From a business perspective, Evolent Health generates revenue primarily through two streams: provider services and performance-based contracts. For its provider services, Evolent signs agreements with healthcare providers, offering them proprietary technology and consulting services, all designed to enhance their operational efficiency and clinical capabilities. The performance-based contracts, which are fundamental in a value-based care environment, allow Evolent to share in the financial benefits realized by its clients from improved patient care and cost savings. This model not only aligns Evolent's success with that of its clients but also positions the company at the heart of the healthcare value chain, asserting its influence through partnerships that are financially symbiotic.
See Also
What is Evolent Health Inc's Accounts Receivables?
Accounts Receivables
407.9m
USD
Based on the financial report for Sep 30, 2024, Evolent Health Inc's Accounts Receivables amounts to 407.9m USD.
What is Evolent Health Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
43%
Over the last year, the Accounts Receivables growth was 3%. The average annual Accounts Receivables growth rates for Evolent Health Inc have been 33% over the past three years , 40% over the past five years , and 43% over the past ten years .
You don't have any saved screeners yet
